Back
Also listed as
FSNUF
OTC
Day Range
$12.79
$12.82
52-Week Range
$9.78
$33.93
Volume
3,496
50D / 200D Avg
$14.39
/
$13.88
Prev Close
$12.89
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 245.3 | 0.4 |
| P/B | 5.9 | 2.9 |
| ROE % | 2.4 | 3.9 |
| Net Margin % | 2.2 | 3.8 |
| Rev Growth 5Y % | -11.9 | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
Hold
$9.30
-27.5%
Forward P/E
14.1
Forward EPS
$0.91
EPS Growth (est.)
+0.0%
Est. Revenue
24 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.33
$1.31 – $1.34
|
30 B | 1 |
| FY2029 |
$1.21
$1.19 – $1.22
|
28 B | 1 |
| FY2028 |
$1.10
$1.08 – $1.11
|
26 B | 1 |
Key Takeaways
Revenue declined -11.92% annually over 5 years
ROE of 2.44% is below average
Generating 1.52B in free cash flow
P/E of 245.29 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9.83%
Cash machine — converts 323.57% of earnings into free cash flow
Growth
Revenue Growth (5Y)
-11.92%
Revenue (1Y)-2.09%
Earnings (1Y)N/A
FCF Growth (3Y)-18.26%
Quality
Return on Equity
2.44%
ROIC4.04%
Net Margin2.16%
Op. Margin8.16%
Safety
Debt / Equity
0.69
Current Ratio1.27
Interest Coverage3.26
Valuation
P/E Ratio
245.29
P/B Ratio5.91
EV/EBITDA71.30
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.09% | Revenue Growth (3Y) | -26.88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -41.41% |
| Revenue Growth (5Y) | -11.92% | Earnings Growth (5Y) | -27.52% |
| Profitability | |||
| Revenue (TTM) | 21.83B | Net Income (TTM) | 471.00M |
| ROE | 2.44% | ROA | 1.08% |
| Gross Margin | 24.63% | Operating Margin | 8.16% |
| Net Margin | 2.16% | Free Cash Flow (TTM) | 1.52B |
| ROIC | 4.04% | FCF Growth (3Y) | -18.26% |
| Safety | |||
| Debt / Equity | 0.69 | Current Ratio | 1.27 |
| Interest Coverage | 3.26 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 245.29 | P/B Ratio | 5.91 |
| P/S Ratio | 5.29 | PEG Ratio | -0.89 |
| EV/EBITDA | 71.30 | Dividend Yield | 0.00% |
| Market Cap | 115.53B | Enterprise Value | 127.06B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 21.83B | 22.30B | 40.84B | 37.52B | 36.28B |
| Net Income | 471.00M | -594.00M | 1.37B | 1.82B | 1.71B |
| EPS (Diluted) | 0.05 | -0.26 | 0.61 | 0.82 | 0.77 |
| Gross Profit | 5.38B | 5.06B | 10.73B | 10.31B | 10.32B |
| Operating Income | 1.78B | 1.14B | 3.51B | 4.16B | 4.39B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 43.55B | 45.28B | 76.42B | 71.96B | 66.65B |
| Total Liabilities | 23.26B | 25.63B | 44.20B | 42.67B | 40.62B |
| Shareholders' Equity | 19.54B | 19.00B | 20.42B | 19.00B | 16.95B |
| Total Debt | 13.58B | 15.83B | 27.76B | 27.16B | 25.91B |
| Cash & Equivalents | 2.05B | 2.29B | 2.18B | 2.61B | 1.84B |
| Current Assets | 11.45B | 12.52B | 18.28B | 17.46B | 15.77B |
| Current Liabilities | 9.01B | 9.33B | 13.66B | 15.06B | 13.22B |